These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15620863)

  • 1. Sustained release of lidocaine from Poloxamer 407 gels.
    Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM
    Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur.
    Zhang L; Parsons DL; Navarre C; Kompella UB
    J Control Release; 2002 Dec; 85(1-3):73-81. PubMed ID: 12480313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
    Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
    Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diffusion behaviors of drugs in thermosensitive in situ gels].
    Wei G; Lu WY; Zheng JM
    Yao Xue Xue Bao; 2004 Mar; 39(3):232-5. PubMed ID: 15171663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation.
    Cafaggi S; Russo E; Caviglioli G; Parodi B; Stefani R; Sillo G; Leardi R; Bignardi G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):19-29. PubMed ID: 18598763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheological characterization of Poloxamer 407 lidocaine hydrochloride gels.
    Ricci EJ; Bentley MV; Farah M; Bretas RE; Marchetti JM
    Eur J Pharm Sci; 2002 Nov; 17(3):161-7. PubMed ID: 12393144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
    Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release of urease from a poloxamer gel matrix.
    Fults KA; Johnston TP
    J Parenter Sci Technol; 1990; 44(2):58-65. PubMed ID: 2338605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of thermo-sensitive injectable hydrogel with sustained release of doxorubicin: rheological characterization and in vivo evaluation in rats.
    Xuan JJ; Yan YD; Oh DH; Choi YK; Yong CS; Choi HG
    Drug Deliv; 2011 Jul; 18(5):305-11. PubMed ID: 21226548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release and dura mater permeability of lidocaine and ibuprofen from injectable poloxamer-based gels.
    Paavola A; Yliruusi J; Rosenberg P
    J Control Release; 1998 Mar; 52(1-2):169-78. PubMed ID: 9685947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
    Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
    Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle.
    Sherif S; Bendas ER; Badawy S
    Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of thermosensitive poloxamer 407 gel systems for the sustained release of estradiol in a fish model.
    Cespi M; Bonacucina G; Pucciarelli S; Cocci P; Perinelli DR; Casettari L; Illum L; Palmieri GF; Palermo FA; Mosconi G
    Eur J Pharm Biopharm; 2014 Nov; 88(3):954-61. PubMed ID: 25194925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled release of morphine from a poloxamer 407 gel.
    Jansen MM; Verzijl JM; Burger DM; Hekster YA
    Int J Pharm; 2013 Aug; 452(1-2):266-9. PubMed ID: 23707252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injectable thermally responsive mucoadhesive gel for sustained protein delivery.
    Mayol L; Biondi M; Quaglia F; Fusco S; Borzacchiello A; Ambrosio L; La Rotonda MI
    Biomacromolecules; 2011 Jan; 12(1):28-33. PubMed ID: 21142090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterization of a formulation of butorphanol tartrate in a poloxamer 407 base intended for use as a parenterally administered slow-release analgesic agent.
    Laniesse D; Smith DA; Knych HK; Mosley C; Guzman DS; Beaufrère H
    Am J Vet Res; 2017 Jun; 78(6):677-687. PubMed ID: 28541144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zero-order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow.
    Ali M; Horikawa S; Venkatesh S; Saha J; Hong JW; Byrne ME
    J Control Release; 2007 Dec; 124(3):154-62. PubMed ID: 17964678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis.
    Kelly HM; Deasy PB; Ziaka E; Claffey N
    Int J Pharm; 2004 Apr; 274(1-2):167-83. PubMed ID: 15072793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.